Notes / Company

Alivus Life Sciences Ltd.

ALIVUS BSE 543322 ISIN INE03Q201024 CDMO

Fundamentals

Market cap: ₹13,603 cr
P/E: 24.10×
ROE: 17.24%
Debt / equity: 0.00
Div yield: 0.45%
52-week range: 819.00 — 1148.40

Research on Tijori Finance

Company snapshot

Alivus Life Sciences Ltd.

CDMO

₹12,715 cr

P/E 22.53×

Latest quarter · Mar 2026

Sales₹689 cr

Net profit₹163 cr

Op. margin+31.1%

EPS₹13.25

Strength & growth

Debt / equity0.00×

Current ratio4.97×

The timeline — 1 note on Alivus Life Sciences Ltd.

May 2026

21 May 26 · 3:23 PM IST Brief

Brief · Earnings · Mid cap

Alivus Life Sciences Q4 transcript adds colour, not surprise

The 83-page record of the May 15 concall confirms known numbers and elaborates on Dahej fire and CDMO timelines, but holds no incremental market-moving news.

Verify on exchange BSE filings for ALIVUS NSE filings for ALIVUS Tijori Finance company page